These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 32445654)

  • 21. Secreted GRP78 activates EGFR-SRC-STAT3 signaling and confers the resistance to sorafeinib in HCC cells.
    Li R; Yanjiao G; Wubin H; Yue W; Jianhua H; Huachuan Z; Rongjian S; Zhidong L
    Oncotarget; 2017 Mar; 8(12):19354-19364. PubMed ID: 28423613
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Kurarinol induces hepatocellular carcinoma cell apoptosis through suppressing cellular signal transducer and activator of transcription 3 signaling.
    Shu G; Yang J; Zhao W; Xu C; Hong Z; Mei Z; Yang X
    Toxicol Appl Pharmacol; 2014 Dec; 281(2):157-65. PubMed ID: 24997323
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNA-340 inhibits the proliferation and invasion of hepatocellular carcinoma cells by targeting JAK1.
    Yuan J; Ji H; Xiao F; Lin Z; Zhao X; Wang Z; Zhao J; Lu J
    Biochem Biophys Res Commun; 2017 Jan; 483(1):578-584. PubMed ID: 27998770
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Loss of suppressors of cytokine signaling 3 promotes aggressiveness in hepatocellular carcinoma.
    Wu WY; Kim H; Zhang CL; Meng XL; Wu ZS
    J Invest Surg; 2014 Aug; 27(4):197-204. PubMed ID: 24476004
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PKM2 promotes cell metastasis and inhibits autophagy via the JAK/STAT3 pathway in hepatocellular carcinoma.
    Yu Z; Wang D; Tang Y
    Mol Cell Biochem; 2021 May; 476(5):2001-2010. PubMed ID: 33512635
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Downregulation of signal transducer and activator of transcription 3 by sorafenib: a novel mechanism for hepatocellular carcinoma therapy.
    Hung MH; Tai WT; Shiau CW; Chen KF
    World J Gastroenterol; 2014 Nov; 20(41):15269-74. PubMed ID: 25386075
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MiR-137 suppresses migration and invasion by targeting EZH2-STAT3 signaling in human hepatocellular carcinoma.
    Huang B; Huang M; Li Q
    Pathol Res Pract; 2018 Dec; 214(12):1980-1986. PubMed ID: 30274685
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Suppression of signal transducer and activator of transcription 3 activation by butein inhibits growth of human hepatocellular carcinoma in vivo.
    Rajendran P; Ong TH; Chen L; Li F; Shanmugam MK; Vali S; Abbasi T; Kapoor S; Sharma A; Kumar AP; Hui KM; Sethi G
    Clin Cancer Res; 2011 Mar; 17(6):1425-39. PubMed ID: 21131551
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protopanaxadiol inhibits epithelial-mesenchymal transition of hepatocellular carcinoma by targeting STAT3 pathway.
    Yang L; Zhang XY; Li K; Li AP; Yang WD; Yang R; Wang P; Zhao ZH; Cui F; Qin Y; Yang JH; Tao HL; Sun T; Chen S; Yu PH; Liu HJ; Yang C
    Cell Death Dis; 2019 Aug; 10(9):630. PubMed ID: 31431619
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amygdalin promotes the activity of T cells to suppress the progression of HBV-related hepatocellular carcinoma via the JAK2/STAT3 signaling pathway.
    Wang R; Zhang D; Sun K; Peng J; Zhu W; Yin S; Tang D; Wu Y
    BMC Infect Dis; 2021 Jan; 21(1):56. PubMed ID: 33435880
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DNMT3b/OCT4 expression confers sorafenib resistance and poor prognosis of hepatocellular carcinoma through IL-6/STAT3 regulation.
    Lai SC; Su YT; Chi CC; Kuo YC; Lee KF; Wu YC; Lan PC; Yang MH; Chang TS; Huang YH
    J Exp Clin Cancer Res; 2019 Nov; 38(1):474. PubMed ID: 31771617
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Honokiol inhibits signal transducer and activator of transcription-3 signaling, proliferation, and survival of hepatocellular carcinoma cells via the protein tyrosine phosphatase SHP-1.
    Rajendran P; Li F; Shanmugam MK; Vali S; Abbasi T; Kapoor S; Ahn KS; Kumar AP; Sethi G
    J Cell Physiol; 2012 May; 227(5):2184-95. PubMed ID: 21792937
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Scutellarin-induced apoptosis in HepG2 hepatocellular carcinoma cells via a STAT3 pathway.
    Xu H; Zhang S
    Phytother Res; 2013 Oct; 27(10):1524-8. PubMed ID: 23192830
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quercetin shows anti-tumor effect in hepatocellular carcinoma LM3 cells by abrogating JAK2/STAT3 signaling pathway.
    Wu L; Li J; Liu T; Li S; Feng J; Yu Q; Zhang J; Chen J; Zhou Y; Ji J; Chen K; Mao Y; Wang F; Dai W; Fan X; Wu J; Guo C
    Cancer Med; 2019 Aug; 8(10):4806-4820. PubMed ID: 31273958
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CKLF1 Enhances Inflammation-Mediated Carcinogenesis and Prevents Doxorubicin-Induced Apoptosis via IL6/STAT3 Signaling in HCC.
    Liu Y; Liu L; Zhou Y; Zhou P; Yan Q; Chen X; Ding S; Zhu F
    Clin Cancer Res; 2019 Jul; 25(13):4141-4154. PubMed ID: 30918019
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Total alkaloids of Rubus aleaefolius Poir. inhibit the STAT3 signaling pathway leading to suppression of proliferation and cell cycle arrest in a mouse model of hepatocellular carcinoma.
    Zhao J; Lin W; Cao Z; Liu L; Zhuang Q; Zhong X; Hong Z; Peng J
    Oncol Rep; 2013 Sep; 30(3):1309-14. PubMed ID: 23828071
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel anti-cancer agent Icaritin suppresses hepatocellular carcinoma initiation and malignant growth through the IL-6/Jak2/Stat3 pathway.
    Zhao H; Guo Y; Li S; Han R; Ying J; Zhu H; Wang Y; Yin L; Han Y; Sun L; Wang Z; Lin Q; Bi X; Jiao Y; Jia H; Zhao J; Huang Z; Li Z; Zhou J; Song W; Meng K; Cai J
    Oncotarget; 2015 Oct; 6(31):31927-43. PubMed ID: 26376676
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A sorafenib derivative and novel SHP-1 agonist, SC-59, acts synergistically with radiotherapy in hepatocellular carcinoma cells through inhibition of STAT3.
    Huang CY; Tai WT; Hsieh CY; Hsu WM; Lai YJ; Chen LJ; Shiau CW; Chen KF
    Cancer Lett; 2014 Jul; 349(2):136-43. PubMed ID: 24735751
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long non-coding RNA FEZF1-AS1 promotes cell invasion and epithelial-mesenchymal transition through JAK2/STAT3 signaling pathway in human hepatocellular carcinoma.
    Wang YD; Sun XJ; Yin JJ; Yin M; Wang W; Nie ZQ; Xu J
    Biomed Pharmacother; 2018 Oct; 106():134-141. PubMed ID: 29957463
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Maintenance of stemness by miR-589-5p in hepatocellular carcinoma cells promotes chemoresistance via STAT3 signaling.
    Long J; Jiang C; Liu B; Dai Q; Hua R; Chen C; Zhang B; Li H
    Cancer Lett; 2018 Jun; 423():113-126. PubMed ID: 29196128
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.